9 Recruiting Interstitial Lung Disease Phase 2 Clinical Trials
Active phase 2 studies for interstitial lung disease enrolling across the USA. Verify eligibility and contact site coordinators.
All Interstitial Lung Disease studiesPhase 2 Studies for Interstitial Lung Disease
🟢 Recruiting Phase2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase2
Pulmonary Hypertension SOLAR
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
129Xe MRI Cardiopulmonary
📍 Duke University Medical Center — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
📍 NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
📍 aTyr Investigative Site — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔